0001179110-17-006246.txt : 20170428
0001179110-17-006246.hdr.sgml : 20170428
20170428150311
ACCESSION NUMBER: 0001179110-17-006246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170426
FILED AS OF DATE: 20170428
DATE AS OF CHANGE: 20170428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Ramesh
CENTRAL INDEX KEY: 0001580074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 17794693
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
4
1
edgar.xml
FORM 4 -
X0306
4
2017-04-26
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001580074
Kumar Ramesh
C/O ONCONOVA THERAPEUTICS, INC.
375 PHEASANT RUN
NEWTOWN
PA
18940
1
1
0
0
President and CEO
Common Stock
2017-04-26
4
P
0
23810
2.10
A
102227
D
37,510 shares are held by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee.
/s/ Mark Guerin as attorney-in-fact
2017-04-28